Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN49285450
ISRCTN49285450
Completed
N/A

A randomised trial to investigate the effects of pre-natal and infancy nutritional supplementation on infant immune development

Medical Research Council (MRC) (UK) - International Nutrition Group0 sites875 target enrollmentNovember 12, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Medical Research Council (MRC) (UK) - International Nutrition Group
Enrollment
875
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

  1. 2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/23057665 2. 2014 results in http://www.ncbi.nlm.nih.gov/pubmed/24125806 3. 2016 results in https://www.ncbi.nlm.nih.gov/pubmed/28003540 4. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28424258 5. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28490512 6. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30773140 7. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31386660 (added 10/01/2020) 8. 2021 results in https://pubmed.ncbi.nlm.nih.gov/33784438/ (added 31/03/2021)
Registry
who.int
Start Date
November 12, 2009
End Date
September 30, 2013
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Medical Research Council (MRC) (UK) - International Nutrition Group

Eligibility Criteria

Inclusion Criteria

  • •Amended as of 04/10/2010:
  • •Women (aged 18 to 45 years) resident in Kiang West Region, The Gambia, with pregnancy confirmed by urine test and ultrasound examination and with gestational age approximately 10 \- 20 weeks.
  • •Initial information at time of registration:
  • •Women (aged 18 to 45 years) resident in Kiang West Region, The Gambia, with pregnancy confirmed by urine test and ultrasound examination and with gestational age approximately 12 weeks

Exclusion Criteria

  • •Amended as of 04/10/2010:
  • •1\. Currently enrolled in another MRC study or current pregnancy (beyond 20 weeks on ultrasound assessment)
  • •2\. Severe anaemia (haemoglobin \[Hb] less than 7 g/dL)
  • •3\. Reported onset of menopause
  • •Initial information at time of registration:
  • •1\. Currently enrolled in another MRC study or current pregnancy (beyond 12 weeks on ultrasound assessment)
  • •2\. Severe anaemia (haemoglobin \[Hb] less than 7 g/dL)
  • •3\. Reported onset of menopause

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
The evaluation of the Preparing For Life early childhood Intervention programmeSchool readinessNot Applicable
ISRCTN04631728niversity College Dublin (Ireland)233
Completed
N/A
Sensory Re-learning after Carpal Tunnel syndromeMusculoskeletal impairment associated with Carpal tunnel syndromeNervous System DiseasesCarpal tunnel syndrome
ISRCTN30848329niversity of East Anglia (UK)30
Completed
N/A
A pragmatic randomised clinical trial of the effectiveness and cost effectiveness of targeted population screening for low bone mineral density (BMD) in the prevention of neck of femur fracturesPrevention of osteoporotic/fragility fracturesMusculoskeletal DiseasesOsteoporosis
ISRCTN11021925niversity of East Anglia (UK)800
Completed
N/A
urse vs patient management of postop pai
ISRCTN10868989orfolk and Norwich University Hospital NHS Trust (UK)144
Completed
N/A
The action of gabapentin for the management of chronic pelvic pain in women (GaPP)Chronic pelvic painMusculoskeletal DiseasesPelvic and perineal pain
ISRCTN70960777niversity of Edinburgh (UK)60